| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3280114 | B | Binding affinity to calf thymus DNA at 25 uM by visible and near-UV CD spectrophotometry | Bos taurus | 1 | nucleic acid format | Scientific Literature | ||
| 2. | ALA3280115 | B | Binding affinity to bacteriophage PM2 DNA at 25 uM by visible and near-UV CD spectrophotometry | Pseudoalteromonas phage PM2 | 1 | assay format | Scientific Literature | ||
| 3. | ALA3280233 | B | Binding affinity to calf thymus DNA at 37.1 uM by visible and near-UV CD spectrophotometry | Bos taurus | 1 | nucleic acid format | Scientific Literature | ||
| 4. | ALA3280234 | F | Antibacterial activity against Bacillus subtilis Marburg assessed as growth inhibition | Bacillus subtilis | 2 | organism-based format | Scientific Literature | ||
| 5. | ALA3280235 | F | Antibacterial activity against Penicillin-resistant Staphylococcus aureus assessed as growth inhibition | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
| 6. | ALA3280236 | F | Antibacterial activity against Sarcina subflava assessed as growth inhibition | Sarcina | 2 | organism-based format | Scientific Literature | ||
| 7. | ALA3280238 | F | Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival time at 0.0125 mg/kg/injection, ip administered daily for 9 days (Rvb = 9.6 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA3280240 | F | Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival time at 0.15 mg/kg/injection, ip administered intermittently on days 1, 5 and 9 (Rvb = 9.6 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA3280242 | F | Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival time at 0.2 mg/kg/injection, ip administered as single dose (Rvb = 9.6 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA3280244 | F | Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 0.0125 mg/kg/injection, ip administered daily for 9 days | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA3280246 | F | Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in lifespan at 0.15 mg/kg/injection, ip administered intermittently on days 1, 5 and 9 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA3280248 | F | Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 0.2 mg/kg/injection, ip administered as single dose | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA3280250 | F | Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mean survival time at 0.1 mg/kg/injection, ip administered daily for 9 days (Rvb = 10.5 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA3280252 | F | Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mean survival time at 0.15 mg/kg/injection, ip administered intermittently on days 1, 5 and 9 (Rvb = 10.5 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA3280254 | F | Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as mean survival time at 0.2 mg/kg/injection, ip administered as single dose (Rvb = 10.5 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA3280256 | F | Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in life span at 0.1 mg/kg/injection, ip administered daily for 9 days measured on day 60 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA3280258 | F | Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in life span at 0.15 mg/kg/injection, ip administered intermittently on days 1, 5 and 9 measured on day 60 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA3280597 | F | Antitumor activity against mouse P388 cells allografted in BDF1 mouse assessed as increase in life span at 0.2 mg/kg/injection, ip administered as single dose measured on day 60 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA3280599 | F | Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as mean survival time at 0.05 mg/kg/injection, ip administered daily for 9 days (Rvb = 28 days) | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA3280601 | F | Antitumor activity against mouse B16 cells allografted in BDF1 mouse assessed as mean survival time at 0.075 mg/kg/injection, ip administered intermittently on days 1, 5 and 9 (Rvb = 28 days) | Mus musculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!